Revance Therapeutics, Inc. (RVNC)
Largest Insider Buys in Sector
RVNC Stock Price History Chart
RVNC Stock Performance
About Revance Therapeutics, Inc.
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing DaxibotulinumtoxinA in preclinical trial for the treatment of migraine, as well as a topical program for various indications; and OnabotulinumtoxinA, a biosimilar to BOTOX. The company has a collaboration and license agreement with Viatris Inc. to develop, manufacture, and commercialize onabotulinumtoxinA. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Insider Activity of Revance Therapeutics, Inc.
Over the last 12 months, insiders at Revance Therapeutics, Inc. have bought $209,400 and sold $2.05M worth of Revance Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Revance Therapeutics, Inc. have bought $629,471 and sold $5.33M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Foley Mark J (CEO) — $418,800.
The last purchase of 30,000 shares for transaction amount of $209,400 was made by Foley Mark J (CEO) on 2024‑03‑06.
List of Insider Buy and Sell Transactions, Revance Therapeutics, Inc.
| 2024-04-16 | Sale | Jordan Erica | Chief Commercial Officer | 2,392 0.0023% | $3.80 | $9,096 | -20.47% | |
| 2024-03-18 | Sale | Schilke Tobin | CFO | 9,361 0.0092% | $5.04 | $47,204 | -27.33% | |
| 2024-03-18 | Sale | Sjuts Dustin S | President | 9,211 0.009% | $5.04 | $46,446 | -27.33% | |
| 2024-03-18 | Sale | Moxie Dwight | CLO & GC | 8,125 0.008% | $5.04 | $40,971 | -27.33% | |
| 2024-03-06 | Foley Mark J | CEO | 30,000 0.0377% | $6.98 | $209,400 | -41.32% | ||
| 2023-09-06 | Sale | Moxie Dwight | SVP, GC & Secretary | 11,000 0.0126% | $17.06 | $187,704 | -64.72% | |
| 2023-09-05 | Sale | Moxie Dwight | SVP, GC & Secretary | 23,853 0.0276% | $17.81 | $424,920 | -65.81% | |
| 2023-08-03 | Sale | Foley Mark J | CEO | 26,279 0.0307% | $22.57 | $593,151 | -72.39% | |
| 2023-07-03 | Sale | Foley Mark J | CEO | 26,279 0.0322% | $24.94 | $655,333 | -72.16% | |
| 2023-07-03 | Sale | Schilke Tobin | CFO | 1,701 0.0021% | $25.04 | $42,593 | -72.16% | |
| 2023-06-15 | Sale | Kolaja Carey OConnor | director | 2,500 0.003% | $28.24 | $70,600 | -74.85% | |
| 2023-06-09 | Sale | Foley Mark J | CEO | 31,279 0.0397% | $30.72 | $960,928 | -75.29% | |
| 2023-06-09 | Sale | Sjuts Dustin S | President | 5,000 0.0064% | $30.82 | $154,096 | -75.29% | |
| 2023-06-02 | Sale | Schilke Tobin | CFO | 500 0.0006% | $31.00 | $15,500 | -75.42% | |
| 2023-06-01 | Sale | Schilke Tobin | CFO | 2,701 0.0033% | $30.57 | $82,570 | -74.75% | |
| 2023-05-15 | Sale | Foley Mark J | CEO | 70,447 0.0886% | $34.55 | $2.43M | -75.34% | |
| 2023-05-15 | Sale | Sjuts Dustin S | President | 21,015 0.0264% | $34.55 | $726,003 | -75.34% | |
| 2023-05-15 | Sale | Schilke Tobin | CFO | 21,401 0.0269% | $34.55 | $739,338 | -75.34% | |
| 2023-05-15 | Sale | Moxie Dwight | SVP, GC & Secretary | 21,401 0.0269% | $34.55 | $739,338 | -75.34% | |
| 2023-05-01 | Sale | Schilke Tobin | CFO | 3,201 0.0039% | $31.70 | $101,472 | -73.21% |
Insider Historical Profitability
| Foley Mark J | CEO | 1015468 0.957% | $2.34 | 3 | 5 | +21.46% |
| Sjuts Dustin S | President | 167550 0.1678% | $2.34 | 0 | 4 | |
| Jordan Erica | Chief Commercial Officer | 114864 0.1102% | $2.34 | 0 | 1 | |
| Schilke Tobin | CFO | 192666 0.091% | $2.34 | 0 | 12 | |
| Moxie Dwight | SVP, GC & Secretary | 137815 0.0502% | $2.34 | 0 | 6 | |
| Browne L Daniel | CEO and President | 151193 0.1722% | $2.34 | 1 | 16 | +60.04% |
| Rankin Aubrey | President, Innovation & Tech | 95463 0.1087% | $2.34 | 1 | 10 | +14.59% |
| SILVERNAIL LAUREN P | CFO & CBO | 65497 0.0746% | $2.34 | 1 | 8 | +53.99% |
| Bertolino Arthur Peter | EVP and Chief Medical Officer | 34001 0.0387% | $2.34 | 0 | 1 | |
| Russell Angus C. | director | 26913 0.0306% | $2.34 | 1 | 0 | +9.71% |
| Waugh Jacob | Chief Scientific Officer | 25000 0.0285% | $2.34 | 0 | 2 | |
| Ruegg Curtis | EVP, Technical Operations | 23944 0.0273% | $2.34 | 0 | 25 | |
| Kolaja Carey OConnor | director | 16561 0.0189% | $2.34 | 0 | 1 | |
| Allouche Cyril | Principal Accounting Officer | 6400 0.0073% | $2.34 | 0 | 6 | |
| Vickers Philip J. | director | 6150 0.007% | $2.34 | 1 | 0 | <0.0001% |
| GARDNER PHYLLIS | director | 3000 0.0034% | $2.34 | 0 | 1 |
Institutional Investor Ownership
| Capital World Investors | $68.61M | 13.35 | 13.95M | +16.81% | +$9.87M | 0.01 | |
| BlackRock | $35.98M | 7 | 7.31M | -1.89% | -$693,188.65 | <0.01 | |
| Franklin Templeton Investments | $30.91M | 6.02 | 6.28M | +32.3% | +$7.55M | 0.01 | |
| The Vanguard Group | $26.56M | 5.17 | 5.4M | +6.49% | +$1.62M | <0.01 | |
| Palo Alto Investors Lp | $25.82M | 5.02 | 5.25M | +0.2% | +$52,742.40 | 2.91 | |
| Polar Capital | $19.11M | 3.72 | 3.88M | +22.58% | +$3.52M | 0.11 | |
| JPMorgan Chase | $15.51M | 3.02 | 3.15M | -32.09% | -$7.33M | <0.01 | |
| Barclays | $14.86M | 2.89 | 3.02M | +744.44% | +$13.1M | 0.01 | |
| Helm Capital Management LLC | $13.07M | 2.54 | 2.66M | +81.79% | +$5.88M | 0.39 | |
| State Street | $11.61M | 2.26 | 2.36M | -6.46% | -$801,546.73 | <0.0001 | |
| Stonepine Capital Management Llc | $9.72M | 1.89 | 1.98M | New | +$9.72M | 7.85 | |
| Geode Capital Management | $9.7M | 1.89 | 1.97M | +2.41% | +$228,399.64 | <0.01 | |
| Cibc Asset Management Inc | $8.56M | 1.67 | 1.74M | +51.71% | +$2.92M | 0.03 | |
| Suvretta Capital Management, LLC | $7.87M | 1.53 | 1.6M | New | +$7.87M | 0.33 | |
| Federated Hermes | $7.7M | 1.5 | 1.56M | +1,804.06% | +$7.29M | 0.02 | |
| Morgan Stanley | $5.92M | 1.15 | 1.2M | +36.92% | +$1.6M | <0.0001 | |
| Bamco | $5.04M | 0.98 | 1.02M | 0% | +$0 | 0.01 | |
| Northern Trust | $4.26M | 0.83 | 865,229 | -2.51% | -$109,750.45 | <0.01 | |
| Opaleye Management Inc | $3.86M | 0.75 | 785,000 | New | +$3.86M | 0.61 | |
| Marshall Wace | $3.84M | 0.75 | 781,223 | New | +$3.84M | 0.01 | |
| Rice Hall James & Associates, LLC | $3.67M | 0.71 | 746,139 | -1.57% | -$58,592.28 | 0.22 | |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | $3.45M | 0.67 | 701,707 | +47.46% | +$1.11M | 0.33 | |
| Charles Schwab | $3.44M | 0.67 | 700,050 | +3.35% | +$111,615.12 | <0.01 | |
| Walleye Capital | $3.06M | 0.6 | 622,126 | -32.95% | -$1.5M | 0.01 | |
| Perceptive Advisors | $2.95M | 0.57 | 600,000 | New | +$2.95M | <0.01 | |
| Goldman Sachs | $2.67M | 0.52 | 543,449 | -30.65% | -$1.18M | <0.01 | |
| Bank of America | $2.48M | 0.48 | 504,676 | +141.85% | +$1.46M | <0.0001 | |
| Sio Capital Management LLC | $2.31M | 0.45 | 468,871 | New | +$2.31M | 0.82 | |
| Essex Woodlands Management Inc | $2.25M | 0.44 | 457,085 | 0% | +$0 | 0.65 | |
| GHOST TREE CAPITAL LLC | $2.21M | 0.43 | 450,000 | +20% | +$369,000.00 | 0.72 | |
| Hightower Advisors | $2.19M | 0.43 | 445,387 | +9.59% | +$191,773.61 | <0.01 | |
| Renaissance Technologies | $1.84M | 0.36 | 373,700 | New | +$1.84M | <0.01 | |
| Nuveen | $1.73M | 0.34 | 352,042 | -33.98% | -$891,277.86 | <0.01 | |
| Blair William Co Il | $1.62M | 0.32 | 329,267 | +12.4% | +$178,684.60 | 0.01 | |
| BNY Mellon | $1.5M | 0.29 | 304,564 | -9.14% | -$150,655.33 | <0.0001 | |
| D. E. Shaw & Co. | $1.47M | 0.29 | 298,110 | -27.6% | -$559,108.72 | <0.01 | |
| Schroder Investment Management Group | $1.42M | 0.28 | 288,726 | 0% | +$0 | <0.01 | |
| Dcf Advisers Llc | $1.3M | 0.25 | 263,372 | +2.53% | +$31,979.99 | 0.8 | |
| Two Sigma | $1.27M | 0.25 | 257,397 | New | +$1.27M | <0.01 | |
| Ubs Oconnor Llc | $1.25M | 0.24 | 254,667 | +132.22% | +$713,400.20 | 0.11 | |
| Cm Management Llc | $1.23M | 0.24 | 250,000 | +233.33% | +$861,000.00 | 0.06 | |
| Moore Capital Management | $1.23M | 0.24 | 250,000 | +66.67% | +$492,000.00 | 0.02 | |
| Alphacentric Advisors Llc | $1.21M | 0.24 | 245,000 | +11.36% | +$123,000.00 | 0.77 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $1.08M | 0.21 | 220,160 | +79.84% | +$480,885.63 | 0.22 | |
| Tang Capital Management, LLC | $984,000.00 | 0.19 | 200,000 | New | +$984,000.00 | <0.01 | |
| Assenagon Asset Management S.A. | $978,322.00 | 0.19 | 198,846 | 0% | +$0 | <0.01 | |
| Swiss National Bank | $957,678.00 | 0.19 | 194,650 | +18.22% | +$147,600.00 | <0.01 | |
| UBS | $935,745.00 | 0.18 | 190,192 | -2.04% | -$19,488.13 | <0.0001 | |
| Credit Suisse | $886,329.00 | 0.17 | 180,148 | +4.73% | +$40,053.76 | <0.01 | |
| Tejara Capital Ltd | $836,400.00 | 0.16 | 170,000 | New | +$836,400.00 | 0.28 |